已发表的部分文献: 标题:Serum lipid and blood pressure responses to quercetin vary in overweight patients by apolipoprotein E genotype.作者:Egert S, Boesch-Saadatmandi C, Wolffram S, Rimbach G, Müller MJ;杂志名称:J Nutr 标题:Combination of antithrombin and recombinant thrombomodulin modulates neutrophil cell-death and decreases circulating DAMPs levels in endotoxemic rats.作者:Iba T, Miki T, Hashiguchi N, Tabe Y, Nagaoka I;杂志名称:Thromb Res 标题:Anticancer potential of Tinospora cordifolia and arabinogalactan against benzo(a)pyrene induced pulmonary tumorigenesis: a study in relevance to various biomarkers作者:Mohan V, Koul A;杂志名称:J Herbmed Pharmacol. 标题:Role of Histone Deacetylase Inhibitor in Diabetic Painful Neuropathy.作者:Thakur V, Gonzalez MA, Parada M, Martinez RD, Chattopadhyay M;杂志名称:Mol Neurobiol Epigentek 公司是全球领先的表观遗传学相关研究的技术创新者和产品开发供应商。开发了超过700多个专利产品,为表观遗传学方面的研究和新药研发提供全面系统的解决方案,涵盖样品制备、DNA/RNA甲基化(5-mc, 5-hmc, 5-fc, m6A)/DNMT分析、ChIP、组蛋白甲基化/乙酰化/去乙酰化/磷酸化/SUMO-等领域,提供小分子抑制剂、蛋白质、抗体、以及分析试剂盒产品。